Literature DB >> 24612341

Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Jeremy P Grummet1, Mahesha Weerakoon, Sean Huang, Nathan Lawrentschuk, Mark Frydenberg, Daniel A Moon, Mary O'Reilly, Declan Murphy.   

Abstract

OBJECTIVE: To determine the rate of hospital re-admission for sepsis after transperineal (TP) biopsy using both local data and worldwide literature, as there is growing interest in TP biopsy as an alternative to transrectal ultrasonography (TRUS)-guided biopsy for patients undergoing repeat prostate biopsy. PATIENTS AND METHODS: Pooled prospective databases on TP biopsy from multiple centres in Melbourne were queried for rates of re-admission for infection. A literature review of PubMed and Embase was also conducted using the search terms: 'prostate biopsy, fever, infection, sepsis, septicaemia and complications'.
RESULTS: In all, 245 TP biopsies were performed (111 at Alfred Health, 92 at Epworth Healthcare, 38 at Peter MacCallum Cancer Centre, and four at other institutions). The rate of hospital re-admission for infection was zero. The literature review showed that the rate of sepsis after TRUS biopsy appears to be rising with increasing rates of multi-resistant bacteria found in rectal flora, and is as high as 5%. However, the rate of sepsis from published series of TP biopsy approached zero.
CONCLUSIONS: Both local and international data suggest a negligible rate of sepsis with TP biopsy. This compares to a concerning rise in the rate of sepsis after TRUS biopsy due to the increasing prevalence of multi-resistant bacteria in rectal flora. Although TRUS biopsy is convenient, cheap and quick to perform, we think that TP biopsy should now be offered as an option, not only to patients undergoing repeat prostate biopsy, but to all patients in whom a prostate biopsy is indicated.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  infection; prostate; sepsis; transperineal biopsy; transrectal biopsy

Mesh:

Substances:

Year:  2014        PMID: 24612341     DOI: 10.1111/bju.12536

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  58 in total

Review 1.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

2.  An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.

Authors:  Stephen J Summers; Darshan P Patel; Blake D Hamilton; Angela P Presson; Mark A Fisher; William T Lowrance; Andrew W Southwick
Journal:  World J Urol       Date:  2015-05-03       Impact factor: 4.226

3.  [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].

Authors:  C Kesch; J P Radtke; F Distler; S Boxler; T Klein; C Hüttenbrink; K Hees; W Roth; M Roethke; H P Schlemmer; M Hohenfellner; B A Hadaschik
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

Review 4.  Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.

Authors:  Michael Kongnyuy; Arvin K George; Ardeshir R Rastinehad; Peter A Pinto
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

5.  One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis.

Authors:  Alessandro Tafuri; Akbar N Ashrafi; Suzanne Palmer; Aliasger Shakir; Giovanni E Cacciamani; Atsuko Iwata; Tsuyoshi Iwata; Jie Cai; Akash Sali; Chhavi Gupta; Luis G Medina; Mariana C Stern; Vinay Duddalwar; Manju Aron; Inderbir S Gill; Andre Abreu
Journal:  World J Urol       Date:  2019-06-07       Impact factor: 4.226

6.  Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: A Prospective Randomised Controlled Trial.

Authors:  Zhengtong Lv; Huichuan Jiang; Xiheng Hu; Changzhao Yang; Harripersaud Chand; Congyi Tang; Yuan Li
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-06-03       Impact factor: 5.554

7.  Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.

Authors:  Aaron Reed; Luca F Valle; Uma Shankavaram; Andra Krauze; Aradhana Kaushal; Erica Schott; Theresa Cooley-Zgela; Bradford Wood; Peter Pinto; Peter Choyke; Baris Turkbey; Deborah E Citrin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-18       Impact factor: 7.038

8.  Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis.

Authors:  Lana Pepdjonovic; Guan Hee Tan; Sean Huang; Sarah Mann; Mark Frydenberg; Daniel Moon; Uri Hanegbi; Adam Landau; Ross Snow; Jeremy Grummet
Journal:  World J Urol       Date:  2016-12-16       Impact factor: 4.226

9.  Radical prostatectomy in the presence of ongoing refractory ESBL Escherichia coli bacterial prostatitis.

Authors:  Louise Catherine McLoughlin; T E D McDermott; John Alan Thornhill
Journal:  BMJ Case Rep       Date:  2014-10-14

10.  Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events.

Authors:  Takeshi Namekawa; Satoshi Fukasawa; Atsushi Komaru; Masayuki Kobayashi; Yusuke Imamura; Takayuki Ohzeki; Kimiaki Takagi; Yosuke Sato; Koichiro Akakura; Tomohiko Ichikawa; Takeshi Ueda
Journal:  Int J Clin Oncol       Date:  2015-04-28       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.